S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

STRATA Skin Sciences Stock Forecast, Price & News

-0.04 (-2.65%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
3,200 shs
Average Volume
232,785 shs
Market Capitalization
$50.52 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive SSKN News and Ratings via Email

Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter.

STRATA Skin Sciences logo

About STRATA Skin Sciences

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The company was founded by Dina Gutkowicz-Krusin in December 1989 and is headquartered in Horsham, PA.


STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Short Interest Update
November 19, 2021 |  americanbankingnews.com
STRATA Skin Sciences (NASDAQ:SSKN) Issues Earnings Results
November 11, 2021 |  americanbankingnews.com
STRATA Skin Sciences Announces CFO Transition
October 4, 2021 |  sg.finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$23.09 million
Book Value
$0.77 per share


Net Income
$-4.41 million
Pretax Margin




Free Float
Market Cap
$50.52 million
Not Optionable

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)

Social Links


Overall MarketRank

1.34 out of 5 stars

Medical Sector

1137th out of 1,391 stocks

Surgical & Medical Instruments Industry

109th out of 125 stocks

Analyst Opinion: 0.0Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

STRATA Skin Sciences (NASDAQ:SSKN) Frequently Asked Questions

How has STRATA Skin Sciences' stock been impacted by Coronavirus?

STRATA Skin Sciences' stock was trading at $1.42 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SSKN shares have increased by 3.5% and is now trading at $1.47.
View which stocks have been most impacted by COVID-19

Are investors shorting STRATA Skin Sciences?

STRATA Skin Sciences saw a drop in short interest in October. As of October 29th, there was short interest totaling 19,800 shares, a drop of 33.3% from the October 14th total of 29,700 shares. Based on an average daily trading volume, of 70,200 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.1% of the shares of the company are sold short.
View STRATA Skin Sciences' Short Interest

When is STRATA Skin Sciences' next earnings date?

STRATA Skin Sciences is scheduled to release its next quarterly earnings announcement on Wednesday, March 23rd 2022.
View our earnings forecast for STRATA Skin Sciences

How were STRATA Skin Sciences' earnings last quarter?

STRATA Skin Sciences, Inc. (NASDAQ:SSKN) released its quarterly earnings data on Wednesday, November, 10th. The medical device company reported ($0.02) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.05) by $0.03. STRATA Skin Sciences had a negative net margin of 8.32% and a negative trailing twelve-month return on equity of 17.12%. During the same period in the prior year, the firm posted ($0.04) EPS.
View STRATA Skin Sciences' earnings history

When did STRATA Skin Sciences' stock split? How did STRATA Skin Sciences' stock split work?

STRATA Skin Sciences's stock reverse split on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split.

Who are STRATA Skin Sciences' key executives?

STRATA Skin Sciences' management team includes the following people:
  • Robert J. Moccia, President, Chief Executive Officer & Director
  • Christopher Lesovitz, Chief Financial Officer
  • Brent Cowgill, Vice President-Marketing
  • Jay Sturm, Secretary & General Counsel

What other stocks do shareholders of STRATA Skin Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Trevena (TRVN), Amarin (AMRN), Biocept (BIOC), Kopin (KOPN), OPKO Health (OPK), Plug Power (PLUG), AbbVie (ABBV), SCYNEXIS (SCYX), Tonix Pharmaceuticals (TNXP) and Agile Therapeutics (AGRX).

What is STRATA Skin Sciences' stock symbol?

STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."

Who are STRATA Skin Sciences' major shareholders?

STRATA Skin Sciences' stock is owned by many different retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (3.68%), Cannell Capital LLC (2.54%) and Western Standard LLC (1.38%).
View institutional ownership trends for STRATA Skin Sciences

Which major investors are selling STRATA Skin Sciences stock?

SSKN stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.
View insider buying and selling activity for STRATA Skin Sciences
or view top insider-selling stocks.

Which major investors are buying STRATA Skin Sciences stock?

SSKN stock was acquired by a variety of institutional investors in the last quarter, including Western Standard LLC, and Cannell Capital LLC.
View insider buying and selling activity for STRATA Skin Sciences
or or view top insider-buying stocks.

How do I buy shares of STRATA Skin Sciences?

Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STRATA Skin Sciences' stock price today?

One share of SSKN stock can currently be purchased for approximately $1.47.

How much money does STRATA Skin Sciences make?

STRATA Skin Sciences has a market capitalization of $50.52 million and generates $23.09 million in revenue each year. The medical device company earns $-4.41 million in net income (profit) each year or ($0.07) on an earnings per share basis.

How many employees does STRATA Skin Sciences have?

STRATA Skin Sciences employs 109 workers across the globe.

What is STRATA Skin Sciences' official website?

The official website for STRATA Skin Sciences is www.strataskinsciences.com.

Where are STRATA Skin Sciences' headquarters?

STRATA Skin Sciences is headquartered at 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044.

How can I contact STRATA Skin Sciences?

STRATA Skin Sciences' mailing address is 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044. The medical device company can be reached via phone at (215) 619-3200, via email at [email protected], or via fax at 215-619-3208.

This page was last updated on 11/29/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.